Theragen Etex Co.,Ltd. (KOSDAQ:066700)

South Korea · Delayed Price · Currency is KRW

2,590.00

-10.00 (-0.38%)

At close: Mar 6, 2026

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Pharmaceutical Business	236.31B	203.31B	170.81B	144.46B	123.47B
Pharmaceutical Business Growth	16.23%	19.03%	18.23%	17.01%	2.90%
Health Care and Genome Analysis Business	18.65B	20.99B	24.47B	23.00B	20.40B
Health Care and Genome Analysis Business Growth	-11.17%	-14.22%	6.41%	12.72%	4.88%
Consolidation Reconciliation Journal Entry	-1.37B	-1.24B	-1.90B	-896.67M	-847.33M
Suspended Business	-3.97B	-6.59B	-2.61B	-	-
Total	249.63B	216.47B	190.77B	166.57B	143.02B
Total Growth	15.32%	13.47%	14.53%	16.46%	3.58%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
South Korea	247.45B	213.90B	188.08B	164.00B	141.73B
South Korea Growth	15.69%	13.72%	14.69%	15.71%	3.80%
Overseas	2.18B	2.57B	2.68B	2.57B	1.29B
Overseas Growth	-15.39%	-4.18%	4.55%	99.01%	-16.46%
Total	249.63B	216.47B	190.77B	166.57B	143.02B
Total Growth	15.32%	13.47%	14.53%	16.46%	3.58%

Source: S&P Global Market Intelligence.